EXCLAIM Investigators. Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study - Turpie, AG; Hull, RD; Schellong, SM (Stroke, 2013)
et al.